UE integrates R&D, manufacturing, sales, and after-sales service. Our products are CE, FDA, South Korea KFDA, and CFDA approved and have complied with local regulatory requirements. UE has strived to develop and enhance our products to empower anesthesiologists to convey a sense of expertise in all possible conditions, being fully aware that anesthesiologists race against time to save lives, and the primary step is tracheal intubations in a few precious seconds. That leads to our commitment: Empower healthcare professionals to save lives. Today UE consists of 4 R&D centers in LA, Shenzhen, Shanghai, and Hangzhou and 2 sales centers in Boston and Shanghai. Over 150 remarkable R&D professionals are collaborating with eminent clinical experts, scientific research institutes, and top universities worldwide to deliver innovative solutions based on clinical needs and feedback. By the end of 2020, UE has sold to 5 continents (countries and regions including the US, Germany, France, the UK, Italy, the Netherlands, South Korea, etc.) As the main driver of the trend of substituting video laryngoscopes for direct laryngoscope in China, we have accounted for over 80% market share, covered 6,800+ medium and large hospitals & 80% of Tier 3 hospitals (top 1,400+), and prepared 11,000+ out of 90,000+ anesthesiologists for intubation. We are pleased that UE products had been introduced as model airway management tools for the "Intubation Team" fighting against COVID-19 on main-stream media like CGTN, CCTV1/13 Xinwen Lianbo, News 30', Focus Report, etc. UE offers four strategic lines: 1. Airway management: Video Laryngoscope (with single-use blades, with single-use sleeves, reusable/disposable), Flexible Videoscope (reusable/disposable), Video Laryngeal Mask, and Video Stylet; 2. Endoscopy: Flexible Bronchoscope (resusable/disposable); 3. EnT: Video Otoscope, Rhinoscope, and Laryngoscope; 4. Minimally invasive surgical device: disposable laparoscopic trocar.